Evolution of the Average Target: IRADIMED CORPORATION

Evolution of the Average Target - IRADIMED CORPORATION

Evolution of the Target Price: IRADIMED CORPORATION

Evolution of the Target Price - IRADIMED CORPORATION

Changes in Analyst Recommendations: IRADIMED CORPORATION

c64611cedfda37bb5c391d6e1886efe.vk-jES3xpZ7snXOqCboflhth75PWwe1s2iaAFkAYhek.iwuQa2aDiM6710Xlb_VJpmlWo-Xg8pdUtHDoICEh99j0AupXFLrDwZv2Mg~52743e7f0a8e41d9f402cc29193c7297

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+36.07%
+5.34%
+10.08%
+8.12%
+10.96%
+7.34%
+8.45%
+2.34%
+5.74%
+5.84%
Average +10.03%
Weighted average by Cap. +7.31%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
86.72USD
Average target price
118.00USD
Spread / Average Target
+36.07%
High Price Target
120.00USD
Spread / Highest target
+38.38%
Low Price Target
116.00USD
Spread / Lowest Target
+33.76%

Analyst Consensus Detail

Analyst consensus - IRADIMED CORPORATION

Consensus revision (last 18 months)

Consensus revision (last 18 months) - IRADIMED CORPORATION
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - IRADIMED CORPORATION
  1. Stock Market
  2. Stocks
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION